pulmonary-hypertension

Documents about pulmonary-hypertension

• This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)#467668ClinicalTrials.gov
• Preoperative Pulmonary Systolic Pressure and Outcome After Non-cardiac Surgery:Threshold Analysis#444774ClinicalTrials.gov
• Macitentan to Prevent PRVO#1045346ClinicalTrials.gov
• New Orleans Pulmonary Hypertension Biobank#146321ClinicalTrials.gov
• Pulmonary Hypertension in Transfusion Dependent Thalassemic Children in a Tertiary Care Hospital#427371HAL (France)
• A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension#813903ClinicalTrials.gov
• A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction#840652ClinicalTrials.gov
• Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients#888334ClinicalTrials.gov
• HRV as a Marker of Treatment Response in PAH Arterial Hypertension#968083ClinicalTrials.gov
• Balloon Pulmonary Angioplasty in Non-operable CTEPH Patients#668896ClinicalTrials.gov
• Subcutaneous Elafin in Healthy Subjects#18765ClinicalTrials.gov
• CVD/PH and Voice Characteristics#127735ClinicalTrials.gov
• Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan#158099ClinicalTrials.gov
• Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy#123604ClinicalTrials.gov
• To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.#201676ClinicalTrials.gov
• Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)#234517ClinicalTrials.gov
• A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.#238215ClinicalTrials.gov
• A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease#356568ClinicalTrials.gov
• Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)#890714ClinicalTrials.gov
• Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension#914598ClinicalTrials.gov
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.#918957ClinicalTrials.gov
• Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,#842645ClinicalTrials.gov
• Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR#201633ClinicalTrials.gov
• Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation#467653ClinicalTrials.gov
• Consistency of Electrical Cardiometry and Pulmonary Artery Catheter#878115ClinicalTrials.gov
• Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)#902163ClinicalTrials.gov
• A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy#195419ClinicalTrials.gov
• Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia#369925ClinicalTrials.gov
• A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD#390981ClinicalTrials.gov
• Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)#969436ClinicalTrials.gov
• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease#623570ClinicalTrials.gov
• PAH Exercise Study#143719ClinicalTrials.gov
• New International CTEPH Database#325190ClinicalTrials.gov
• RUS-registry of PH#332846ClinicalTrials.gov
• Clinical Updates in Pulmonary Hypertension.#351480NCBI PubMed Central
• Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib#426671ClinicalTrials.gov
• Tyvaso Dosing and Titration Evaluation: TyTRATE Registry#448154ClinicalTrials.gov
• Olaparib for PAH: a Multicenter Clinical Trial#623585ClinicalTrials.gov
• Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With Previous Formulae#311003ClinicalTrials.gov
• Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism#451553ClinicalTrials.gov
• Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary Hypertension#296590ClinicalTrials.gov
• Elucidation of mechanisms underlying the therapeutic effects of cordycepin on pulmonary hypertension, with a focus on cell senescence and gut microbiota#338813OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).#407797ClinicalTrials.gov
• Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review#476165IRIS
• A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)#813488ClinicalTrials.gov
• Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension#852184ClinicalTrials.gov
• Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension#857874ClinicalTrials.gov
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)#874620ClinicalTrials.gov
• Comparison of Sequential to Initial Combination Therapy in PAH#904597ClinicalTrials.gov
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension#909675ClinicalTrials.gov